Paul Bisaro bought $28K of MYGN stock

Paul Bisaro, Dir of Myriad Genetics Inc (MYGN), bought 7,500 shares of MYGN stock worth $28K, per an SEC Form 4 filed May 14, 2026.

It was an open-market purchase.

The trade was reported on May 14, 2026.

MYGN has moved +63.5% since the trade date, from $3.62 to $5.92 (Nov 6, 2026 close).